rawpixel-istockphoto-com-trademark-
rawpixel / iStockphoto.com
12 March 2018Big Pharma

Recordati suffers TM setback at General Court

Pharmaceutical company Recordati suffered a setback last week after the EU General Court dismissed its appeal over a trademark registration.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
22 May 2017   Pharmaceutical company Recordati has paid AstraZeneca $300 million for the European commercial rights to beta-blockers.

More on this story

Big Pharma
22 May 2017   Pharmaceutical company Recordati has paid AstraZeneca $300 million for the European commercial rights to beta-blockers.

More on this story

Big Pharma
22 May 2017   Pharmaceutical company Recordati has paid AstraZeneca $300 million for the European commercial rights to beta-blockers.